{"filings":[{"id":528676,"accession_number":"0000856982-26-000030","cik":856982,"company_name":"MERIT MEDICAL SYSTEMS INC","ticker":"MMSI","form_type":"8-K","filed_at":"2026-05-19T20:54:43+00:00","items":["5.02","5.03","5.07","7.01","9.01"],"status":"ready","headline":"Merit Medical shareholders approve 2.7M-share 2026 Equity Plan and re-elect all directors","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Shareholders approved 2.7M share 2026 Equity Incentive Plan and 2026 Employee Stock Purchase Plan at May 13 annual meeting.","Say-on-pay passed with 48.8M for (97.2%); all four director nominees re-elected.","Board adopted amended bylaws updating universal proxy rules, remote meeting, officer composition.","New Director RSU Agreement: 350-day vesting for non-employee director restricted stock units.","Ratified Deloitte as independent auditor for FY2026 with 50.4M shares for."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":3729621266.5740857,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":99223,"accession_number":"0000856982-26-000023","cik":856982,"company_name":"MERIT MEDICAL SYSTEMS INC","ticker":"MMSI","form_type":"8-K","filed_at":"2026-04-30T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Merit Medical Q1 beat: rev $381.9M, EPS $0.94 non-GAAP; acquires View Point Medical for $140M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $381.9M (+7%); GAAP EPS $0.68 (+39%); non-GAAP EPS $0.94 (+9%).","Non-GAAP operating margin 19.7% (up 40 bps); free cash flow $24.7M (+26%).","Acquired View Point Medical (OneMark) for $140M on Apr 1; sold DualCap product line for $28M in Feb.","Reorganized revenue reporting into Foundational and Therapeutic; updated full-year guidance."],"consensus_eps_estimate":null,"consensus_eps_actual":0.68,"consensus_revenue_estimate":null,"consensus_revenue_actual":381877000.0,"consensus_period":"2026-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":3729621266.5740857,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":99222,"accession_number":"0000856982-26-000020","cik":856982,"company_name":"MERIT MEDICAL SYSTEMS INC","ticker":"MMSI","form_type":"8-K","filed_at":"2026-04-13T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Merit Medical Systems provides historical revenue by new product categories for 2022-2025","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Total revenue grew from $1.151B in 2022 to $1.516B in 2025, with foundational revenue at $1.029B and therapeutic at $487M in 2025.","Therapeutic revenue increased 24% year-over-year in 2025, driven by cardiac therapies ($93.4M), endoscopy ($72.5M), and oncology ($96.8M).","Foundational revenue rose to $1.029B in 2025 from $862M in 2022, with access ($588.5M) and OEM ($167.1M) as top platforms.","Quarterly total revenue rose sequentially from $355M in Q1 2025 to $394M in Q4 2025, with therapeutic platform growing each quarter."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":3729621266.5740857,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":99221,"accession_number":"0000856982-26-000018","cik":856982,"company_name":"MERIT MEDICAL SYSTEMS INC","ticker":"MMSI","form_type":"8-K","filed_at":"2026-04-01T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Merit Medical acquires View Point Medical for ~$140M; 2027 non-GAAP EPS accretive","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Total consideration ~$140M; $90M cash at closing, $25M deferred at each of first and second anniversaries.","View Point's OneMark System complements Merit's SCOUT platform for breast lesion localization.","Projected 2026 revenue $2M-$4M, dilutive to non-GAAP EPS by ~$0.05.","Projected 2027 revenue $14M-$16M, accretive to non-GAAP EPS; 20%+ growth, 70% non-GAAP gross margins.","Q1 2026 earnings call scheduled for April 30, 2026."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":3729621266.5740857,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":115103,"accession_number":"0000856982-26-000007","cik":856982,"company_name":"MERIT MEDICAL SYSTEMS INC","ticker":"MMSI","form_type":"8-K","filed_at":"2026-02-24T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Merit Medical Q4 revenue $393.9M (+11% YoY); guides FY2026 EPS $4.01-$4.15","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 revenue $393.9M (+11% YoY); GAAP EPS $0.63 (+37%); Non-GAAP EPS $1.04 (+12%).","FY2025 revenue $1.516B (+12% YoY); GAAP EPS $2.13 (+5%); Non-GAAP EPS $3.83 (+11%).","Q4 Non-GAAP operating margin 21.0% vs 19.6% prior year; Free cash flow $74.0M (+13%).","FY2026 guidance: revenue $1.610-$1.630B (+6-8%); Non-GAAP EPS $4.01-$4.15 (+5-8%).","Constant currency organic revenue grew 7% in both Q4 and FY2025."],"consensus_eps_estimate":null,"consensus_eps_actual":2.13,"consensus_revenue_estimate":null,"consensus_revenue_actual":1515906000.0,"consensus_period":"2025-FY","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":3729621266.5740857,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":115102,"accession_number":"0000856982-26-000002","cik":856982,"company_name":"MERIT MEDICAL SYSTEMS INC","ticker":"MMSI","form_type":"8-K","filed_at":"2026-01-08T23:59:59+00:00","items":["2.02","5.02","7.01","9.01"],"status":"ready","headline":"Merit Medical founder Lampropoulos resigns as Chair; preliminary Q4 revenue up ~10-11% YoY","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Fred P. Lampropoulos resigned as director and Chair on Jan 4, after earlier stepping down as CEO and Executive Chair; three-month consulting agreement at $250K/month.","F. Ann Millner appointed Chair of the Board, effective Jan 5; Board reduced from 11 to 10 members.","Preliminary Q4 2025 revenue $389M–$395M, up 10–11% YoY; constant currency revenue up 8–10% YoY.","Full Q4 and FY 2025 earnings, plus FY 2026 guidance, to be reported on Feb 24, 2026 after market close.","Lampropoulos' resignation not due to any dispute or matter related to financial reporting or operations."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":3729621266.5740857,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":131497,"accession_number":"0000856982-25-000060","cik":856982,"company_name":"MERIT MEDICAL SYSTEMS INC","ticker":"MMSI","form_type":"8-K","filed_at":"2025-11-13T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Merit Medical withdraws WRAPSODY TPT application; CMS deferral delays payment to Jan 2027","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["CMS deferred Merit's Transitional Pass-Through incremental payment application for WRAPSODY CIE to CY2027 rule; Jan 1, 2027 earliest effective date.","Merit withdraws TPT application and will immediately begin full U.S. commercialization of WRAPSODY CIE.","CEO cites strong 24-month efficacy data from WRAPSODY WAVE Trial as key differentiator vs. competitors.","FY2025 U.S. WRAPSODY CIE revenue forecast remains $2M-$4M.","Device received FDA premarket approval Dec 2024; approved by Health Canada Apr 2025."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":3729621266.5740857,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":131496,"accession_number":"0000856982-25-000058","cik":856982,"company_name":"MERIT MEDICAL SYSTEMS INC","ticker":"MMSI","form_type":"8-K","filed_at":"2025-11-03T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Merit Medical closes C2 CryoBalloon acquisition from PENTAX Medical","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Acquired C2 CryoBalloon device and related technology from Pentax of America, Inc., a subsidiary of PENTAX Medical.","Transaction closed on November 3, 2025; definitive asset purchase agreement signed October 17, 2025.","Financial terms of the acquisition were not disclosed in this filing."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":3729621266.5740857,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":131495,"accession_number":"0000856982-25-000055","cik":856982,"company_name":"MERIT MEDICAL SYSTEMS INC","ticker":"MMSI","form_type":"8-K","filed_at":"2025-10-30T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Merit Medical Q3 revenue $384.2M (+13%), non-GAAP EPS $0.92 (+6.7%), updates FY guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q3 revenue $384.2M (+13.0% YoY); constant currency organic revenue +7.8%.","GAAP EPS $0.46 (-3.0%); non-GAAP EPS $0.92 (+6.7%) from prior year.","Free cash flow 9-month $141.6M (+17.6% YoY).","Non-GAAP operating margin 19.7% vs 19.2% a year ago.","Full-year guidance updated; specific figures in press release."],"consensus_eps_estimate":null,"consensus_eps_actual":1.49,"consensus_revenue_estimate":null,"consensus_revenue_actual":1121970000.0,"consensus_period":"2025-Q3","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":3729621266.5740857,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":131494,"accession_number":"0000856982-25-000050","cik":856982,"company_name":"MERIT MEDICAL SYSTEMS INC","ticker":"MMSI","form_type":"8-K","filed_at":"2025-10-17T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Merit Medical signs $22M asset deal to acquire C2 CryoBalloon from PENTAX Medical","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Total consideration $22M: $19M cash at closing plus up to $3M in milestone payments.","Closing expected Q4 2025, subject to customary conditions.","Projected 2026 revenue $6-8M; non-GAAP EPS dilution $0.02-0.03 in 2026, accretive thereafter.","Expands Merit's Endoscopy portfolio targeting Barrett's esophagus and GERD.","PENTAX employees expected to join Merit; manufacturing to transfer to South Jordan, UT."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":3729621266.5740857,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":131493,"accession_number":"0000856982-25-000048","cik":856982,"company_name":"MERIT MEDICAL SYSTEMS INC","ticker":"MMSI","form_type":"8-K","filed_at":"2025-10-10T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Martha Aronson named CEO of Merit Medical as Fred Lampropoulos resigns; remains Chairman","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Aronson appointed President and CEO effective Oct 3, 2025; Lampropoulos resigns as CEO but stays as director and Chairman.","Aronson base salary $1M; signing bonus $250K; target bonus 100% of base; initial equity target $5.5M.","Immediate equity grant of $4.125M in PSUs and RSUs; transition allowance $12K/month through Sep 2026.","Lampropoulos serves as Executive Chairman through Jan 3, 2026, then non-employee director; consulting deal under negotiation.","Board expanded from 10 to 11 to accommodate Aronson's appointment."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":3729621266.5740857,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":148081,"accession_number":"0000856982-25-000045","cik":856982,"company_name":"MERIT MEDICAL SYSTEMS INC","ticker":"MMSI","form_type":"8-K","filed_at":"2025-07-30T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Merit Medical Q2 revenue up 13.2% to $382.5M; non-GAAP EPS $1.01, up 9.8%; appoints new CEO","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $382.5M, +13.2% YoY; constant-currency revenue +12.5%, organic constant-currency +6.7%.","GAAP EPS $0.54 (-11.6%), non-GAAP EPS $1.01 (+9.8%); GAAP operating margin 12.3% vs 13.6% prior year.","Non-GAAP operating margin improved to 21.2% from 20.1%; free cash flow $89.1M in H1 2025, +8.1%.","Acquired Biolife (StatSeal/WoundSeal hemostatic devices); no transaction value disclosed.","Martha Aronson named President & CEO, effective Oct 3, 2025; Fred Lampropoulos becomes Chairman."],"consensus_eps_estimate":null,"consensus_eps_actual":1.03,"consensus_revenue_estimate":null,"consensus_revenue_actual":737813000.0,"consensus_period":"2025-Q2","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":3729621266.5740857,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":148080,"accession_number":"0000856982-25-000041","cik":856982,"company_name":"MERIT MEDICAL SYSTEMS INC","ticker":"MMSI","form_type":"8-K","filed_at":"2025-07-11T23:59:59+00:00","items":["2.02","5.02","9.01"],"status":"ready","headline":"Merit Medical names Martha Aronson as CEO effective Oct 3; preliminary Q2 revenue up ~12-14% YoY","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Martha Aronson appointed President and CEO effective Oct 3, 2025; founder Fred Lampropoulos remains Chairman.","Aronson previously EVP & President of Global Healthcare at Ecolab; 20 years at Medtronic.","Compensation: $1M base salary, $250K signing bonus, target bonus 100% of base, $5.5M initial LTI award, $4.125M equity grant.","Preliminary Q2 2025 revenue $380-384M, up 12-14% YoY; constant currency up 11-13%.","Full Q2 earnings release scheduled for July 30, 2025 after market close."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":3729621266.5740857,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":166832,"accession_number":"0000856982-25-000035","cik":856982,"company_name":"MERIT MEDICAL SYSTEMS INC","ticker":"MMSI","form_type":"8-K","filed_at":"2025-05-20T23:59:59+00:00","items":["1.01","2.02","7.01","9.01"],"status":"ready","headline":"Merit Medical acquires Biolife for $120M in cash; adds StatSeal/WoundSeal hemostasis products","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Purchase price $120M cash; Biolife becomes wholly-owned subsidiary of Merit.","Biolife's revenue projected at ~$18M annualized starting FY 2026 with mid-teens growth.","StatSeal/WoundSeal products address ~$350M global hemostasis market.","Merit reaffirms FY 2025 guidance; acquisition slightly dilutive to 2025 non-GAAP profitability."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":3729621266.5740857,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":166831,"accession_number":"0000856982-25-000033","cik":856982,"company_name":"MERIT MEDICAL SYSTEMS INC","ticker":"MMSI","form_type":"8-K","filed_at":"2025-05-19T23:59:59+00:00","items":["5.07","9.01"],"status":"ready","headline":"Merit Medical shareholders elect 4 directors, approve say-on-pay, ratify Deloitte","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Directors Gunderson, Kaiser, McDonnell, Millner each elected with >48M votes for.","Say-on-pay advisory proposal approved: 50.6M for, 1.7M against.","Ratification of Deloitte & Touche as auditor for FY 2025: 52.1M for, 2.0M against.","No other matters were submitted; 54.2M shares represented of 59.1M entitled."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.15,"market_cap_usd":3729621266.5740857,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":166830,"accession_number":"0000856982-25-000025","cik":856982,"company_name":"MERIT MEDICAL SYSTEMS INC","ticker":"MMSI","form_type":"8-K","filed_at":"2025-04-24T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Merit Medical Q1 2025 revenue $355.4M up 9.8% YoY; non-GAAP EPS $0.86 up 14.8%","summary_kind":"llm","event_type":"earnings","confidence":"medium","bullets":["GAAP EPS $0.49 up 2.0%; non-GAAP EPS $0.86 up 14.8% vs Q1 2024.","GAAP operating margin 11.5% vs 11.1%; non-GAAP margin 19.3% vs 17.0% YoY.","Constant currency revenue up 10.9%; organic constant currency revenue up 6.0%.","Free cash flow $19.5M, down 20.5% from prior year period.","Full-year 2025 guidance updated; details not fully disclosed in filing excerpt."],"consensus_eps_estimate":null,"consensus_eps_actual":0.49,"consensus_revenue_estimate":null,"consensus_revenue_actual":355351000.0,"consensus_period":"2025-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":3729621266.5740857,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":184234,"accession_number":"0000856982-25-000012","cik":856982,"company_name":"MERIT MEDICAL SYSTEMS INC","ticker":"MMSI","form_type":"8-K","filed_at":"2025-02-25T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Merit Medical Q4 revenue $355M (+9.4%); Non-GAAP EPS $0.93 (+25.8%); FY 2025 guidance issued","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 2024 revenue $355.2M, up 9.4% YoY; constant currency revenue up 10.1%; organic constant currency up 6.1%.","Non-GAAP EPS $0.93, up 25.8%; GAAP EPS $0.46, down 2.6%. Non-GAAP operating margin improved to 19.6% from 16.6%.","Full year 2024 revenue $1.357B (+7.9%); Non-GAAP EPS $3.46 (+21.3%); free cash flow $185.7M (+67.5%).","Completed acquisition of Cook Medical lead management portfolio; FDA PMA received for Wrapsody dialysis device.","FY 2025 guidance: revenue $1.47-1.49B (8-10% growth); Non-GAAP EPS $3.58-$3.70 (4-7% growth)."],"consensus_eps_estimate":null,"consensus_eps_actual":2.03,"consensus_revenue_estimate":null,"consensus_revenue_actual":1356514000.0,"consensus_period":"2024-FY","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":3729621266.5740857,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":184233,"accession_number":"0000856982-25-000006","cik":856982,"company_name":"MERIT MEDICAL SYSTEMS INC","ticker":"MMSI","form_type":"8-K","filed_at":"2025-01-28T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Merit Medical hosts investor call on WRAPSODY CIE; prepared remarks truncated in filing","summary_kind":"llm","event_type":"other_material","confidence":"low","bullets":["Conference call held January 28, 2025, to discuss commercial and marketing updates for the WRAPSODY CIE stent-graft.","Participants include CEO Fred Lampropoulos, EVP R&D John Hall, VP Sales Caleb Konstanski, CFO Raul Parra, and CLO Brian Lloyd.","Dr. Danny Patel, a paid consultant interventional nephrologist, also spoke on the call.","Full content of prepared remarks not available in the furnished exhibit; specific financial or clinical metrics not disclosed."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":3729621266.5740857,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":184232,"accession_number":"0000856982-25-000003","cik":856982,"company_name":"MERIT MEDICAL SYSTEMS INC","ticker":"MMSI","form_type":"8-K","filed_at":"2025-01-14T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Merit Medical prelim FY2024 rev ~$1.356B, up 7.7-7.9% YoY; full results Feb 25","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Preliminary unaudited revenue $1.355B-$1.357B for FY2024, up ~7.7%-7.9% YoY.","Constant currency rev growth 8.4-8.6% YoY; FX impact of $7.9M on reported rev.","Plans to report Q4/FY2024 results and issue FY2025 guidance on Feb 25, 2025 after market close.","Conference call Feb 25, 2025 at 5:00 PM Eastern; registration link available."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":3729621266.5740857,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":200831,"accession_number":"0000856982-24-000105","cik":856982,"company_name":"MERIT MEDICAL SYSTEMS INC","ticker":"MMSI","form_type":"8-K","filed_at":"2024-12-19T23:59:59+00:00","items":["5.02","7.01","9.01"],"status":"ready","headline":"Merit Medical President Joseph Wright resigns amid conduct allegations; CEO Lampropoulos reassumes President role","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["President Joseph C. Wright resigns effective Jan 3, 2025, following allegations investigated by independent directors.","Allegations unrelated to Merit's operations or financial performance; no material misconduct affecting business found.","CEO Fred P. Lampropoulos, age 75, re-appointed as President; he previously held the role from 1987 to May 2024.","Under separation agreement, Wright retains vested stock options, forfeits unvested equity; receives salary through resignation date.","Lampropoulos is brother-in-law of Wright; no change to his compensation as disclosed in April 2024 proxy."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":3729621266.5740857,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":200830,"accession_number":"0000856982-24-000100","cik":856982,"company_name":"MERIT MEDICAL SYSTEMS INC","ticker":"MMSI","form_type":"8-K","filed_at":"2024-11-01T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"Merit Medical completes $210M cash acquisition of Cook Medical's lead management portfolio","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Closed on November 1, 2024; consideration ~$210M cash plus assumption of certain liabilities.","Funded from cash on hand and borrowings under Merit's long-term credit facility.","Portfolio includes medical devices for pacemaker/ICD lead removal; strengthens electrophysiology and CRM business.","CEO Fred Lampropoulos says acquisition enhances Merit's position in the global cardiac intervention market.","Wells Fargo advised Merit; Bank of America advised Cook Medical."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":3729621266.5740857,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":200829,"accession_number":"0000856982-24-000094","cik":856982,"company_name":"MERIT MEDICAL SYSTEMS INC","ticker":"MMSI","form_type":"8-K","filed_at":"2024-10-30T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Merit Medical Q3 revenue up 7.8% to $339.8M, non-GAAP EPS $0.86, raises guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $339.8M (+7.8% YoY); GAAP EPS $0.48 (+8.0%); non-GAAP EPS $0.86 (+21.1%).","Non-GAAP operating margin 19.2% vs 17.4% prior year; free cash flow $120M in 9 months (+116%).","Acquired assets from EndoGastric Solutions (EsophyX Z+ for GERD treatment).","Entered asset purchase for Cook Medical lead management portfolio; closing expected Nov 1, 2024.","Raised full-year guidance; specifics not detailed in press release excerpt."],"consensus_eps_estimate":null,"consensus_eps_actual":1.57,"consensus_revenue_estimate":null,"consensus_revenue_actual":1001356000.0,"consensus_period":"2024-Q3","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":3729621266.5740857,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":216832,"accession_number":"0000856982-24-000087","cik":856982,"company_name":"MERIT MEDICAL SYSTEMS INC","ticker":"MMSI","form_type":"8-K","filed_at":"2024-09-18T23:59:59+00:00","items":["1.01","2.02","7.01","9.01"],"status":"ready","headline":"Merit Medical to buy Cook Medical's lead management portfolio for $210M cash; reaffirms FY2024 guidance","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Acquires Cook Medical's lead management portfolio for ~$210M cash; closing expected in Q4 2024.","Projected to add ~$40M annualized revenue starting FY2025, with strong growth profile in global lead management market.","Reaffirms full-year 2024 guidance issued Aug 1; updated outlook includes projected post-close acquisition impact.","Positive 6-month WAVE trial results: WRAPSODY arm achieved 89.8% patency vs 62.8% for standard PTA (p<0.0001)."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":3729621266.5740857,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":216831,"accession_number":"0000856982-24-000076","cik":856982,"company_name":"MERIT MEDICAL SYSTEMS INC","ticker":"MMSI","form_type":"8-K","filed_at":"2024-08-01T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Merit Medical Q2 revenue $338M (+5.6%), GAAP EPS $0.61 (+75.7%), raises FY guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $338.0M, up 5.6% YoY; constant currency revenue up 6.6%.","GAAP EPS $0.61, up 75.7%; Non-GAAP EPS $0.92, up 16.8%.","GAAP operating margin 13.6% vs 9.0%; Non-GAAP operating margin 20.1% vs 19.1%.","Raised full-year 2024 revenue and EPS guidance.","WRAPSODY WAVE study 6-month outcomes to be presented at CIRSE Sept 14-16; FDA PMA under review."],"consensus_eps_estimate":null,"consensus_eps_actual":1.09,"consensus_revenue_estimate":null,"consensus_revenue_actual":661511000.0,"consensus_period":"2024-Q2","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":3729621266.5740857,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":216830,"accession_number":"0000856982-24-000065","cik":856982,"company_name":"MERIT MEDICAL SYSTEMS INC","ticker":"MMSI","form_type":"8-K","filed_at":"2024-07-01T23:59:59+00:00","items":["1.01","2.02","7.01","9.01"],"status":"ready","headline":"Merit Medical acquires EndoGastric Solutions' EsophyX Z+ device for $105M; updates 2024 guidance","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Asset purchase of EsophyX Z+ device for $105M cash, financed via credit facility draws.","Projected to add ~$30M annualized revenue, leveraging existing GI endoscopy commercial footprint.","Modestly dilutive to full-year 2024 non-GAAP profitability but expected accretive in first full year post-closing.","Reaffirmed standalone 2024 guidance; updated outlook to include partial-year impact; details on Aug 1 Q2 call."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":3729621266.5740857,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":236561,"accession_number":"0000856982-24-000050","cik":856982,"company_name":"MERIT MEDICAL SYSTEMS INC","ticker":"MMSI","form_type":"8-K","filed_at":"2024-05-21T23:59:59+00:00","items":["1.01","5.02","5.03","5.07","8.01","9.01"],"status":"ready","headline":"Merit shareholders elect Silvia M. Perez as director; bylaws updated for new President role","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Silvia M. Perez, President of 3M's Commercial Branding & Transportation Division, elected to Board for three-year term.","Joseph C. Wright appointed President; Fred P. Lampropoulos remains CEO; bylaws revised to separate CEO and President duties.","Shareholders approved amendment to 2018 Long-Term Incentive Plan, adding 3,000,000 authorized shares.","Advisory say-on-pay proposal passed with ~96% of votes cast in favor.","Deloitte & Touche ratified as independent auditor for FY 2024."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":3729621266.5740857,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":236560,"accession_number":"0000856982-24-000045","cik":856982,"company_name":"MERIT MEDICAL SYSTEMS INC","ticker":"MMSI","form_type":"8-K","filed_at":"2024-05-16T23:59:59+00:00","items":["5.02","8.01","9.01"],"status":"ready","headline":"Merit Medical appoints Joe Wright President; Lampropoulos remains CEO","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Joseph C. Wright appointed President effective May 15, 2024, succeeding Fred Lampropoulos, who remains CEO.","Wright previously served as Chief Commercial Officer; he is Lampropoulos's brother-in-law.","Base salary increased to $750,000; target bonus set at 50%; one-time RSU grant of $475,000.","Board continues CEO succession search for Lampropoulos' planned retirement end of 2025, aided by Korn Ferry."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":3729621266.5740857,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":236559,"accession_number":"0000856982-24-000035","cik":856982,"company_name":"MERIT MEDICAL SYSTEMS INC","ticker":"MMSI","form_type":"8-K","filed_at":"2024-04-30T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Merit Medical Q1 2024 revenue $323.5M (+8.7% YoY); GAAP EPS $0.48 (+35.5%)","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $323.5M, up 8.7% YoY; constant currency revenue up 9.3%; organic constant currency up 7.0%.","GAAP operating margin 11.1% vs 8.9% in Q1 2023; non-GAAP operating margin 17.3% vs 16.1%.","GAAP EPS $0.48, up 35.5% from $0.36; non-GAAP EPS $0.77, up 18.7% from $0.64.","Non-GAAP measures include constant currency and organic growth; reconciliations in press release.","No specific guidance update provided; Q1 results discussed on April 30 conference call."],"consensus_eps_estimate":null,"consensus_eps_actual":0.48,"consensus_revenue_estimate":null,"consensus_revenue_actual":323508000.0,"consensus_period":"2024-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":3729621266.5740857,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":null}